BRITISH INTERNATIONAL SCHOOL, PHUKET
The Phuket News Novosti Phuket Khao Phuket

Login | Create Account | Search


US health regulator authorises Pfizer’s COVID pill

US health regulator authorises Pfizer’s COVID pill

WASHINGTON: The US Food and Drug Administration (FDA) yesterday (Dec 22) authorised Pfizer’s COVID pill for high-risk people aged 12 and over, calling it an important milestone in the pandemic that will allow millions to access the treatment.

CoronavirusCOVID-19healthVaccine
By AFP

Thursday 23 December 2021, 09:11AM


Paxlovid, shown here being produced in Germany, is set to be a milestone in the pandemic. Photo: AFP

Paxlovid, shown here being produced in Germany, is set to be a milestone in the pandemic. Photo: AFP

Paxlovid is a combination of two pills taken over five days that was shown in a clinical trial of 2,200 people to be safe and reduced the risk of hospitalisations and deaths among at-risk people by 88% when taken within five days of symptom onset.

“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally - a major step forward in the fight against this global pandemic,” said FDA scientist Patrizia Cavazzoni in a statement.

“This breakthrough therapy, which has been shown to significantly reduce hospitalisations and deaths and can be taken at home, will change the way we treat COVID-19, and hopefully help reduce some of the significant pressures facing our healthcare and hospital systems,” added Pfizer CEO Albert Bourla in a statement.

The FDA stressed it should complement rather than replace vaccines, which remain the frontline tool against the coronavirus.

But pills that are available at pharmacies should be much easier to access than synthetic antibody treatments, which require infusions administered by drip at hospitals or specialised centres.

In an unusual move, the FDA did not convene its customary panel of independent experts to review the in-depth data surrounding Pfizer’s pill ahead of authorisation.

The European Union’s drug regulator last week allowed member states to use Pfizer’s COVID treatment ahead of formal approval, as an emergency measure to curb an Omicron-fueled wave.

The US has agreed to pay US$5.3 billion (B178bn) for 10 million courses, with delivery starting this year and concluding next, according to Pfizer.

The authorisation comes as cases are surging across the United States, driven by Omicron, the most infectious variant seen to date.

Phuket Property

The highly-mutated variant is better able to bypass prior immunity, and health authorities are urging the public to get boosted with mRNA vaccines in order to restore a higher degree of protection.

Unlike vaccines, the COVID pill does not target the ever-evolving spike protein of the coronavirus, which it uses to invade cells. It should in theory be more variant proof, and Pfizer has said preliminary lab studies have backed up that hypothesis.

Paxlovid is a combination of a new molecule, nirmatrelvir, and HIV antiviral ritonavir, that are taken as separate tablets.

Nirmatrelvir blocks the action of an enzyme the virus needs to replicate, while ritonavir slows down nirmatrelvir’s breakdown so it remains in the body for longer and at higher levels.

Possible side effects include impaired sense of taste, diarrhea, high blood pressure and muscle aches, the FDA said.

There are also potential harmful interactions for people using other drugs, and using Paxlovid in people with uncontrolled or undiagnosed HIV-1 infection may lead to HIV-1 drug resistance, the agency added.

Authorisation is still awaited for another COVID pill, developed by Merck, which is also taken over five days and has been shown to reduce hospitalizations and deaths by 30% among high-risk people.

Independent experts voted in favor of that treatment by a narrow margin, but expressed concerns surrounding its safety, such as potential harm to fetuses and possible damage to DNA.

The two treatments work in different ways inside the body, and Pfizer’s pill is not thought to carry the same level of concerns. Merck’s treatment has been greenlit by Britain and Denmark.

Comment on this story

* Please login to comment. If you do not have an account please register below by simply entering a username, password and email address. You can still leave your comment below at the same time.

CAPTCHA

Be the first to comment.

 

Have a news tip-off? Click here

 

Phuket community
Test & Go for overseas arrivals to be restored, fine-tuned

Thailand will win this year the wolrd championship of ping pong... Which tourists will stay the firs...(Read More)


Crocodile sighted off Phuket’s Bang Tao Beach

It’s looking for people without masks seems it endemic in Cherng Talay ...(Read More)


Phuket face mask campaign targeting tourists begins

what a farse... and so how many tourist they found without mask? what did they do to them? mistery.....(Read More)


Phuket vows tough action on unmasked tourists

Start fining the management of establishments that are allowing patrons to ignore the rules. Third s...(Read More)


Phuket face mask campaign targeting tourists begins

Enforce it the GROCERY STORES, please. If we see people without masks, what are we to do ? Arrange...(Read More)


Phuket face mask campaign targeting tourists begins

Very mis-leading scare-mongering headline, In the story itself it clearly states locals and tourist...(Read More)


Phuket face mask campaign targeting tourists begins

Why don't they patrol the shopping malls and stores. Bangla Road is too easy and advanced warni...(Read More)


Patong Police to crack down on face masks

What about Fitness centers. People come with a mask on, take it off in the changing room and are abs...(Read More)


Phuket vows tough action on unmasked tourists

WHO and in this order says. Get vaccinated, keep your distance from others and wear a mask. 2 years ...(Read More)


Test & Go for overseas arrivals to be restored, fine-tuned

Who would have thought that Kurt wouldn't approve? Wonders never cease!!...(Read More)